Gordon Dunn's Insider Trades & SAST Disclosures
Gordon Dunn's most recent trade in Quoin Pharmaceuticals Ltd - ADR was a trade of 122,221 Series G Warrants (right to buy) done . Disclosure was reported to the exchange on Dec. 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gordon Dunn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Dec 2024 | 122,221 | 122,221 | - | - | Series G Warrants (right to buy) | |
| Quoin Pharmaceuticals Ltd ... | Dunn Gordon | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.45 per share. | 23 Dec 2024 | 122,221 | 151,077 | - | 0.4 | 54,999 | Ordinary Shares |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Dec 2024 | 122,221 | 122,221 | - | - | Series F Warrants (right to buy) | |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 338,994 | 338,994 | - | - | Share Option (Right to Buy) | |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 09 Sep 2024 | 10,000 | 18,856 | - | 0.9 | 9,100 | Ordinary Shares |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 09 Sep 2024 | 10,000 | 28,856 | - | 0.7 | 7,100 | Ordinary Shares |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 09 Sep 2024 | 4,000 | 8,856 | - | 0.8 | 3,200 | Ordinary Shares |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 09 Sep 2024 | 4,000 | 4,856 | - | 0.8 | 3,120 | Ordinary Shares |
| Quoin Pharmaceuticals Ltd ... | Gordon Dunn | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 09 Sep 2024 | 856 | 856 | - | 0.8 | 685 | Ordinary Shares |
| Compass Minerals Internati... | Gordon Dunn | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2024 | 444 | 888 | - | - | Restricted Stock Unit | |
| Compass Minerals Internati... | Gordon Dunn | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2024 | 444 | 4,022 (0%) | 0% | 0 | Common Stock | |
| Compass Minerals Internati... | Gordon Dunn | Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.15 per share. | 18 May 2024 | 200 | 3,822 (0%) | 0% | 13.2 | 2,630 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges